Ortivus AB (publ) quarterly report for the period July – September 2020
2020-11-10 08:30
Ortivus’ customer deliveries continue at a high pace despite Covid-19
Highlights July – Sep 2020
- Hardware delivery of 12.0 MSEK to South Central Ambulance Service performed
- Important milestone passed for the delivery project in Singapore
- Ortivus and SCHILLER AG signed a distribution agreement for the Nordic market
Highlights post-period end
- Ortivus begins the process of moving operations, such as production and reparations of MobiMed monitoring equipment, in-house.
July – Sep 2020
- Net sales amounted to 25.4 (10.4) MSEK, which is an increase in sales of 144%
- Operating profit cleared for comparative distortion items amounted to 1.2 (-0.8) MSEK. Operating profit, including comparative distortion items, amounted to 1.2 (-3.3) MSEK
- EBITDA cleared for comparative distortion items, amounted to 2.0 (1.0) MSEK. EBITDA including comparative distortion items, amounted to 2.0 (-1.6) MSEK
- Profit after tax was 1.2 (-3.3) MSEK
- Earnings per share after tax and before and after dilution amounted to 0.03 (-0.09) SEK
Jan – Sep 2020
- Net sales amounted to 85.2 (33.7) MSEK, which is an increase in sales of 154%
- Operating profit cleared for comparative distortion items, amounted to 9.2 (-8.5) MSEK. Operating profit including comparative distortion items, amounted to 9.2 (-13.7) MSEK
- EBITDA cleared for comparative distortion items, amounted to 11.4 (-3.5) MSEK. EBITDA including comparative distortion items, amounted to 11.4 (-8.7) MSEK
- Profit after tax was 9.1 (-14.2) MSEK
- Earnings per share after tax and before and after dilution, amounted to 0.21 (-0.42) SEK
| Amount in KSEK | Jul-Sep 2020 | Jul-Sep 2019 | Jan-Sep 2020 | Jan-Sep 2019 | Jan-Dec 2019 |
| Net sales | 25 351 | 10 407 | 85 719 | 33 747 | 50 848 |
| Gross margin, % | 31% | 28% | 33% | 37% | 41% |
| Operating profit, excl. comparative distortion items |
1 229 | -757 | 9 225 | -8 466 | -10 197 |
| Operating margin, % excl. comparative distortion items |
5% | -7% | 11% | -25% | -20% |
| EBITDA, excl. comparative distortion items |
2 024 | 1 018 | 11 437 | -3 471 | -3 271 |